Skip to main content

Table 1 Baseline characteristics and blood tests of the study participants

From: Non-linear association of plasma level of high-density lipoprotein cholesterol with endobronchial biopsy bleeding in patients with lung cancer

Characteristics Values
Age (year), median (Q1-Q3) 65 (59–70)
Male, n (%) 487 (77.5)
Smoking, n (%) 394 (62.7)
Biopsy bleeding, n (%) 232 (36.9)
Location of lesion, n (%)
 Peripheral bronchi 548 (87.3)
 Central airway 80 (12.7)
Stage, n (%)
 Early 343 (54.6)
 Advanced 285 (45.4)
Histological types, n (%)
 Adenocarcinoma 171 (27.2)
 Squamous cell carcinoma 313 (49.8)
 SCLC 111 (17.7)
 Others 33 (5.3)
Coexisting diseases, n (%)
 COPD 42 (6.7)
 Hypertension 155 (24.7)
 Diabetes 32 (5.1)
 CHD 20 (3.2)
Blood tests, median (Q1-Q3)
 Triglyceride (mmol/L) 1.0 (0.8–1.4)
 TC (mmol/L) 4.1 (3.5–4.8)
 HDL-C (mmol/L) 1.1 (0.9–1.3)
 LDL-C (mmol/L) 2.8 (2.3–3.3)
 Apo E (mg/dL) 3.6 (2.8–4.6)
 Apo B (g/L) 1.0 (0.8–1.2)
 Homocysteine (μmol/L) 13.2 (10.7–16.2)
 WBC (× 109/L) 6.8 (5.5–8.6)
 Neutrophils (×109/L) 4.6 (3.5–6.4)
 Hemoglobin (g/L) 128 (116–139)
 Platelets (×109/L) 224 (172–280)
 CRP (mg/L) 7.7 (1.4–31.1)
 PT (S) 13.0 (12.3–13.6)
 APTT (S) 35.1 (31.8–38.5)
 ALT (IU/L) 17.0 (12.0–25.0)
 AST (IU/L) 23.0 (19.0–28.0)
  1. SCLC Small-cell lung carcinoma; COPD Chronic obstructive pulmonary disease; CHD Coronary heart disease; TC Total cholesterol; HDL-C High density lipoprotein cholesterol; LDL-C Low density lipoprotein cholesterol; Apo, apolipoprotein; WBC White blood cell; CRP C-reactive protein; PT Prothrombin time; APTT Activated partial thromboplastin time; ALT Alanine aminotransferase; AST Aspartate aminotransferase